Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Covax-19
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Medytox
Deal Size : Undisclosed
Deal Type : Collaboration
Vaxine and Medytox partner on Covid-19 vaccine development
Details : The collaboration aims at developing a Covid-19 vaccine called, COVAX-19®, which is currently undergoing late stage animal testing and is based on Vaxine’s proprietary Advax™ adjuvant technology combined with a recombinant SARS-CoV-2 spike protein.
Product Name : Covax-19
Product Type : Vaccine
Upfront Cash : Undisclosed
May 25, 2020
Lead Product(s) : Covax-19
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Medytox
Deal Size : Undisclosed
Deal Type : Collaboration
Reset All
